As of April 16, 2025, Blueprint Medicines (BPMC) has a market cap of $5.21 billion USD. According to our data, Blueprint Medicines is ranked No.2492 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $5.21 B |
-6.06%
|
Dec 31, 2024 | $5.54 B |
-5.44%
|
Dec 29, 2023 | $5.86 B |
110.55%
|
Dec 30, 2022 | $2.78 B |
-59.10%
|
Dec 31, 2021 | $6.80 B |
-4.49%
|
Dec 31, 2020 | $7.12 B |
40.00%
|
Dec 31, 2019 | $5.09 B |
48.60%
|
Dec 31, 2018 | $3.42 B |
-28.51%
|
Dec 29, 2017 | $4.79 B |
168.84%
|
Dec 30, 2016 | $1.78 B |
6.49%
|
Dec 31, 2015 | $1.67 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() First Majestic Silver
AG
|
$3.20 B |
0.851 M
|
![]() Canada
|
![]() Seabridge Gold
SA
|
$1.25 B |
0.000 M
|
![]() Canada
|
![]() First Majestic Silver
AG
|
$3.20 B |
0.851 M
|
![]() Canada
|
Market Cap | = | BPMC Stock Price | * | BPMC Shares Outstanding |
= | $81.45 | * | 63.91 M | |
= | $5.21 B |